Catalyst Wire Dossier Catalyst Wire Dossier

UH-AC 62 XX

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UH-AC 62 XX, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers [Phase 1]

See pricing